5 results  1 of 1 

1 Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT
Kwai Han Yoo
Blood Res.2022;57(S1):75-78.   Published online 2022 April 30     DOI: http://dx.doi.org/10.5045/br.2022.2022055
      
2 Diffusion-weighted Magnetic Resonance Imaging for Predicting Response to Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma: A Systematic Review
Sae Rom Chung, Young Jun Choi, Chong Hyun Suh, Jeong Hyun Lee, Jung Hwan Baek
Korean J Radiol.2019;20(4):649-661.   Published online 2019 February 25     DOI: http://dx.doi.org/10.3348/kjr.2018.0446
   
3 Dual-Energy CT in Patients Treated with Anti-Angiogenic Agents for Non-Small Cell Lung Cancer: New Method of Monitoring Tumor Response?
Yoo Na Kim, Ho Yun Lee, Kyung Soo Lee, Joon Beom Seo, Myung Jin Chung, Myung-Ju Ahn, Keunchil Park, Tae Sung Kim, Chin A Yi
Korean J Radiol.2012;13(6):702-710.   Published online 2012 October 12     DOI: http://dx.doi.org/10.3348/kjr.2012.13.6.702
      
4 Imaging-Based Tumor Treatment Response Evaluation: Review of Conventional, New, and Emerging Concepts
Hee Kang, Ho Yun Lee, Kyung Soo Lee, Jae-Hun Kim
Korean J Radiol.2012;13(4):371-390.   Published online 2012 June 18     DOI: http://dx.doi.org/10.3348/kjr.2012.13.4.371
      
5 Molecularly Targeted Therapy Using Bevacizumab for Non-Small Cell Lung Cancer: a Pilot Study for the New CT Response Criteria
Ho Yun Lee, Kyung Soo Lee, Hye Sun Hwang, Ju Won Lee, Myung-Ju Ahn, Keunchil Park, Tae Sung Kim, Chin A Yi, Myung Jin Chung
Korean J Radiol.2010;11(6):618-626.   Published online 2010 October 29     DOI: http://dx.doi.org/10.3348/kjr.2010.11.6.618
      

 1 of 1